Press release
Leprosy Treatment Market - Global Industry Analysis 2024
Get Free PDF Research Brochure for more Professional and Technical Insights: https://www.coherentmarketinsights.com/insight/request-sample/128
Leprosy Treatment Market Outlook
According to the statistics received by the World Health Organization (WHO), from various regions (138 countries), the number of registered cases of leprosy was 176,176 in 2015, that is 0.18 cases per 10 000 people. The number of new cases shows the degree of sustained transmission of the disease. Global statistics illustrate that 203,600 (96%) of fresh leprosy cases were from 22 key countries. Prevalence of high occurrences is a reminder that some areas around the world show high incidences of the disease and experience very high rate of transmission. According to WHO, around 16 million cases of leprosy have been treated in the last two decades. Governing bodies and governments alike are trying to eradicate the presence of the disease on a global scale. Owing to these factors, the leprosy treatment market is expected to grow at substantial rate over the forecast period (2016–2024).
Leprosy Treatment Market Taxonomy
On the basis of type of leprosy, the global leprosy treatment market is classified into:
-Early and indeterminate leprosy treatment
-Borderline tuberculoid leprosy treatment
-Tuberculoid leprosy treatment
-Borderline leprosy treatment
-Histoid leprosy treatment
-Lepromatous leprosy treatment
-Borderline lepromatous leprosy treatment
-Diffuse leprosy of Lucio and Latapí
On the basis of treatment, the global leprosy treatment market is classified into:
-Multidrug Therapy
-Others
On the basis of type of end user, the global leprosy treatment market is classified into:
-Government
-Hospitals
-Medical Practitioners
-Others
As per National Leprosy Eradication Programme (NLEP), leprosy has been broadly categorized into two segments namely, paucibacillary leprosy (one to five skin lesions, maximum one nerve with skin liaisons) and multibacillary leprosy (over six skin liaisons, more than one nerve with skin liaisons). Early detection of the disease is an important factor for effective treatment, though various drugs are available for late stage leprosy patients. The most common treatment is multidrug therapy. The drugs recommended by WHO multidrug therapy are rifampicin, dapsone, and clofazimine. Among these, rifampicin is most preferred for treatment of leprosy. Treatment with everyday dapsone and monthly treatment with rifampcin for six months is followed for paucibacillary (PB or tuberculoid) cases. For multibacillary (MB or lepromatous) cases, the treatment is a prolongrd one. It includes daily dapsone and clofazimine. Additionally, monthly rifampicin is recommended for 12 months. Side effects, resistance, and relapse rate are low in multidrug therapy. Some of the other drugs available for leprosy treatment are rifadine and rimactane. The leprosy treatment market is projected to witness a steep inlince in the number of novel drugs and availability of the same, due to increasing initiatives across the globe to eradicate this menace.
Leprosy Treatment Market Future Outlook: Asia Pacific to be Key Growth Market
Leprosy has been endemic to mankind since many decades. This needed interference of various governments around the world as well as the World Health Organization. Governments play an important role in the leprosy treatment market. Ever since the introduction of multidrug therapy by WHO in 1982, governments around the world have adopted this treatment procedure on a large scale. Some of them subsidized the treatment to eradicate the presence of the disease from their countries. Therefore government regulation as well as adoption remains the most important driver of the leprosy treatment market.
Asia Pacific, especially India remains one of the most affected countries. As per the World Health Organization reports, about 59% of the new cases reported were from India. According to stats released by the Leprosy Mission Trust, around 127,000 new occurrences of leprosy were reported from India alone during 2013–2014. Out of these, about 46% were women and children. In India, the prevalence rate according to The Leprosy Mission Trust in the year 2014 was about 0.68 per 10,000 population. The National Leprosy Eradication Programme (NLEP) is one such initiative by the Indian government that aims to eradicate the disease from the country by 2018. Therefore, leprosy treatment market in this region is projected to grow at a considerable rate in the near future.
Key Players in Leprosy Treatment Market
Companies operating in the leprosy treatment market include Glaxo Smithcline Pharmaceuticals Ltd., Systopic Laboratories Pvt. Ltd., Acme Pharmaceuticals, Cadila Pharmaceuticals, Macleods Pharmaceuticals, IDPL, Astra Zeneca Pharma India Ltd., Lark Laboratories (UIndia) Ltd., Genetic Pharma, and Novartis International AG.
About Coherent Market Insights:
Coherent Market Insights is a prominent market research and consulting firm offering action-ready syndicated research reports, custom market analysis, consulting services, and competitive analysis through various recommendations related to emerging market trends, technologies, and potential absolute dollar opportunity.
Contact Us:
Mr. Shah
Coherent Market Insights
1001 4th Ave,
#3200
Seattle, WA 98154
Tel: +1-206-701-6702
Email: sales@coherentmarketinsights.com
Visit Coherent Market Insights Blog @ https://blog.coherentmarketinsights.com/
Connect with us on LinkedIn @ https://www.linkedin.com/company/coherent-market-insights
This release was published on openPR.
Permanent link to this press release:
Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.
You can edit or delete your press release Leprosy Treatment Market - Global Industry Analysis 2024 here
News-ID: 459507 • Views: …
More Releases from CMI-Reports
Global Flavored and Functional Water Market Revenue Growth Predicted by 2018-202 …
The global flavored and functional water market was valued at US$ 29.01 Billion in 2017, according to Flavored and Functional Water Market Report, by Ingredients (Vitamins and Minerals, Botanical Extract, Amino Acids, and Others), By Distribution Chanel (Hypermarket, Supermarkets, Convenience Stores, Specialty Stores, Online Channels, and Others), published by Coherent Market Insights. The flavored and functional market is projected to reach US$ 70.32 Billion by 2025, exhibiting a CAGR of 11.98% during the…
PVC Packaging Materials Market – Size, Share, Outlook, and Opportunity Analysi …
Polyvinyl chloride (PVC) packaging material is used in various end-use industries such as personal care, food and beverages, medical, and others, owing to its properties such as light weight, good impact strength, resistance to oil, grease and chemicals, and others. The high versatility of plastic enables in reuse and recycling.
Market Dynamics
PVC packaging requires less fuel to produce as compared to that of other packaging materials such as metal and glass.…
Avocado Oil Market to Witness Widespread Expansion During 2025
Avocado oil is extracted from the Persea Americana fruit and is used as a cooking oil, in cosmetics, and for lubrication, due to its moisturizing and regenerative properties. Avocado fruit is also known as butter pea or vegetable butter originated in Central America. Avocado oil consists high concentration of potassium, vitamins such as A, D, and E, and monounsaturated fats. Some of the properties of avocado oil are high smoke…
Wood Preservatives Market, by Formulation, Application, and Geography - Trends a …
Global Wood Preservatives - Insights
Wood preservatives such as copper azoles, synthetic pyrethroids, creosote and various other preservatives, are the chemicals applied on wood to preserve it from fungi, insects, termites, ants, and other microbes. These preservatives also prevent the wood from decomposition, degradation and decay, and provides a longer life, thereby increasing its durability.
Growth of wood preservatives market is fueled by the use of wood in marine piling, utility fencing,…
More Releases for Leprosy
Leprosy Treatment Market Insights, Trends, Outlook, and Opportunity Analysis, 20 …
Leprosy or Hansen's disease (HD) is a chronic infection caused by Mycobacterium lepromatosis or Mycobacterium leprae bacteria. Leprosy is principally a granulomatous disease. Symptoms of leprosy include reddish skin lesions, loss of sensation, and weakness of hands and muscles. Nerve damage is the primary cause for numbness of muscles. Leprosy is a communicable disease that can be propagated through contact with cough or phlegm of the affected person. Other risk…
Leprosy Treatment Market Opportunity Analysis, 2018-2026
Leprosy or Hansen's disease (HD) is a chronic infection caused by Mycobacterium lepromatosis or Mycobacterium leprae bacteria. Leprosy is principally a granulomatous disease. Symptoms of leprosy include reddish skin lesions, loss of sensation, and weakness of hands and muscles. Nerve damage is the primary cause for numbness of muscles. Leprosy is a communicable disease that can be propagated through contact with cough or phlegm of the affected person. Other risk…
Global Leprosy Treatment Market Industry Trend and Forecast 2025
This report focuses on the global Leprosy Treatment status, future forecast, growth opportunity, key market and key players. The study objectives are to present the Leprosy Treatment development in United States, Europe and China.
Leprosy, also known as Hansen's disease (HD), is a long-term infection by the bacterium Mycobacterium leprae or Mycobacterium lepromatosis. Initially, infections are without symptoms and typically remain this way for 5 to 20 years. Symptoms that develop…
Leprosy Treatment Market Positive long-term growth outlook 2018-2026
Leprosy Treatment Market report 2018-2026 focuses on the major drivers and restraints for the key players. These research report also provides granular analysis of the market share, segmentation, revenue forecasts and geographic regions of the market. The Leprosy Treatment market research report is a professional and in-depth study on the current state of Leprosy Treatment Industry.
The Leprosy Treatment Market research report covers the present scenario and the growth prospects of…
Leprosy Vaccines Market Promising Growth Opportunities over 2018 to 2028
Leprosy is chronic infectious disease caused by Mycobacterium leprae. Leprosy is also referred to as Hansen’s disease. Leprosy affects the skin, mucosal surfaces of the upper respiratory tract, the peripheral nerves and the eyes. Leprosy can occur to the people of all ages from infant to geriatric. The exact reason for transmission of leprosy is not known but it is strongly believed that leprosy is transferred from a leprosy patient…
Leprosy Treatment Market Research Report by Regional Analysis : forecast 2024
Leprosy or Hansen's disease (HD) is a chronic infection caused by Mycobacterium lepromatosis or Mycobacterium leprae bacteria. Leprosy is principally a granulomatous disease. Symptoms of leprosy include reddish skin lesions, loss of sensation, and weakness of hands and muscles. Nerve damage is the primary cause for numbness of muscles. Leprosy is a communicable disease that can be propagated through contact with cough or phlegm of the affected person. Other risk…
